Presented by Dr. Cristina Cusin and Dr. Alex Keuroghlian, this webinar will review the current evidence on the safety and efficacy of ketamine therapy for patients with treatment resistant major depressive disorder. We will present different methods for delivering ketamine and referring patients to treatment and explore other emerging depression treatments. These treatments will be discussed through the lens of providing high-quality, culturally responsive care for LGTBQIA+ patients.
